Mubadala Bio taps four new execs: Mubadala Investment’s new pharma arm, Mubadala Bio, has hired four new senior executives, according to a press release.

Essam Mohamed (LinkedIn) will oversee the firm’s operations as the new CEO. Mohamed’s three-decade career in the pharma industry includes senior positions across global and regional organizations, including Julphar. He has spearheaded the establishment of several startups within the life sciences industry, with expertise in corporate transformation and regulatory compliance. Hamad Husein Al Marzooqi (LinkedIn) joins him as deputy CEO, bringing with him over two decades of experience spanning the UAE, Brazil, Russia, and the UK, as well as a previous tenure at Mubadala.

Other appointments: The firm tapped Atif Azeem (LinkedIn) as chief financial officer following on from senior leadership positions overseeing financial operations, mergers, and divestments. Khalid Abdallah Al Kaf takes on the role of general manager of pharma logistics. He has over two decades of experience in operations management, IT, and digital transformation.

Tags: